Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAGK.L Share News (AGK)

  • There is currently no data for AGK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up

Tue, 05th Nov 2019 11:57

(Sharecast News) - HSBC: Berenberg downgrades to sell with a target price of 490p.
IWG: JP Morgan reiterates neutral with a target price of 410p.

Inchcape: HSBC reiterates buy with a target price of 690p.

Aggreko: Credit Suisse upgrades to outperform with a target price of 905p.

Ashmore: Jefferies reiterates hold with a target price of 520p.

Jupiter Fund Management: Jefferies upgrades to hold with a target price of 350p.

Dixons Carphone: RBC Capital Markets downgrades to sector performer with a target price of 135p.

Babcock International: Barclays initiates at underweight with a target price of 470p.

Hunting: Goldman Sachs downgrades to sell with a target price of 385p.

Micro Focus: Goldman Sachs upgrades to neutral with a target price of 1,000p.

John Wood Group: Goldman Sachs upgrades to neutral with a target price of 445p.

Experian: Barclays reiterates overweight with a target price of 2,650p.

Next: RBC Capital Markets downgrades to sector performer with a target price of 6,800p.

More News
9 Dec 2022 10:27

Aggreko to buy Crestchic in £122m deal

(Sharecast News) - Temporary power supplier Aggreko said on Friday that it has agreed to buy specialist equipment provider Crestchic in a £122m deal.

Read more
6 Aug 2021 18:20

IN BRIEF: Edinburgh court sanctions Albion's takeover of Aggreko

IN BRIEF: Edinburgh court sanctions Albion's takeover of Aggreko

Read more
2 Aug 2021 10:07

Albion puts in place financing for GBP2.32 billion Aggreko acquisition

Albion puts in place financing for GBP2.32 billion Aggreko acquisition

Read more
8 Jul 2021 21:32

IN BRIEF: Aggreko takeover clears antitrust and regulatory hurdle

IN BRIEF: Aggreko takeover clears antitrust and regulatory hurdle

Read more
26 May 2021 11:15

TOP NEWS: Carlyle offers GBP958 million for asthma drug maker Vectura

TOP NEWS: Carlyle offers GBP958 million for asthma drug maker Vectura

Read more
13 May 2021 16:07

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
30 Apr 2021 16:16

EXECUTIVE CHANGES: Prudential names board of Jackson Financial

EXECUTIVE CHANGES: Prudential names board of Jackson Financial

Read more
28 Apr 2021 15:30

EXECUTIVE CHANGES: Ex-Coca-Cola exec, Cafe Rouge founder for Deliveroo

EXECUTIVE CHANGES: Ex-Coca-Cola exec, Cafe Rouge founder for Deliveroo

Read more
26 Apr 2021 17:02

IN BRIEF: Aggreko gains shareholder approval for Albion takeover

IN BRIEF: Aggreko gains shareholder approval for Albion takeover

Read more
21 Apr 2021 22:05

PRESS: Aggreko deal on rocks as shareholder Liontrust wobbles

PRESS: Aggreko deal on rocks as shareholder Liontrust wobbles

Read more
21 Apr 2021 19:06

Aggreko's takeover deal in doubt after Liontrust opposition -Sky News

April 21 (Reuters) - Equipment rental company Aggreko's 2.3 billion pound($3.20 billion) takeover by private equity firms is in doubt because its biggest shareholder Liontrust Asset Management plans to oppose the deal, Sky News reported https://b...

Read more
19 Apr 2021 16:03

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
15 Apr 2021 14:58

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
18 Mar 2021 11:10

Aggreko outgoing Chair Hanna to remain until takeover completion

Aggreko outgoing Chair Hanna to remain until takeover completion

Read more
8 Mar 2021 13:00

Monday broker round-up

(Sharecast News) - Entain: Numis upgrades to add with a target price of 1,675p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.